Opportunity and Strategy Analysis
This report focuses on identifying opportunities and strategies for investing in the global bionics market within the forecast period. It provides a complete analysis of the global market both quantitatively and qualitatively. The quantitative analysis includes market size and revenue data of the total demand, sub-markets, and regional/national levels throughout 2023-2033. Qualitative analysis depicts a full picture of market dynamics and trends including drivers, restraints and challenges, emerging products/market trends, and Porter's Fiver Forces analysis.
Based on the market data and analysis, the report highlights Increasingly Attractive Segments (IAS) and business opportunities in each segmentation. Moreover, a systematic evaluation of Internal Risks (factors arising within the industry development) and External Risks (factors arising from the surrounding environments) is provided for the bionics industry and market. All the identified risk factors are measured quantitatively according to GMD's novel numeric system, i.e. each risk is evaluated with GMD Risk Index Number (GMD RIN) and GMD Risk Intensity Level (GMD RIL). This in-depth risk assessment offers a comprehensive understanding of the current risk factors and their developing trends. Furthermore, this report concludes risk management strategies and Critical Success Factors (CSFs) to help companies make intelligence-based business decisions in the global bionics industry.
Market Coverage & Overview
The report is based on studies for 2021-2023 and provides a forecast from 2024 till 2033 with 2023 as the base year. Considering impact of COVID-19 and regional conflicts such as Russia-Ukraine war, the trend and outlook of global market is forecast in optimistic, balanced, and conservative scenarios. In the balanced view, the global bionics market is expected to reach $59.94 billion by 2033, growing by 11.4% annually over the coming years.
Segmentation Analysis
Highlighted with 96 tables and 97 figures, this 192-page report represents a 360-degree view on the global market with extensively detailed segmentations by Application, Technology, Fixation, End User, and Region/Country as shown below. Annual revenue 2023-2033 for each segment is included in the report.
By Application
• Medical Bionics
o Bionic Orthopaedic (Bionic Limbs, Bionic Hands, Exoskeletons, Bionic Fingers, and Electrical Bone Growth Stimulators)
o Bionic Heart (Artificial Organs, Pacemakers, Ventricular Assist Device)
o Bionic Brain (Internal Neurostimulators, External Neurostimulators)
o Bionic Ear (Cochlear Implants, Bone Anchored Hearing Systems and Auditory Brainstem Implants)
o Bionic Eye/Vision
• Defense Bionics
o Full Body Military Exoskeletons
o Lower Body Powered Military Exoskeletons
o Passive Military Exoskeletons
o Energy Scavenging Military Exoskeletons
o Stationary Military Exoskeletons
• Industrial Bionics
By Technology
• Mechanical Bionics
• Electronic Bionics
By Fixation
• Implantable Bionics
• Externally Worn Bionics
By End User
• Hospitals
• Military
• Clinics & Diagnostic Centers
• Industrial Users
• Other End Users
By Region
• North America (U.S., Canada, and Mexico)
• Europe (Germany, UK, France, Spain, Italy, Russia, Rest of Europe; Rest of Europe is further segmented into Netherlands, Switzerland, Poland, Sweden, Belgium, Austria, Ireland, Norway, Denmark, and Finland)
• APAC (Japan, China, Australia, India, South Korea, and Rest of APAC; Rest of APAC is further segmented into Malaysia, Singapore, Indonesia, Thailand, New Zealand, Vietnam, Taiwan, and Philippines)
• South America (Brazil, Chile, Argentina, Rest of South America)
• MEA (UAE, Saudi Arabia, South Africa, and Rest of MEA)
The breakdown of all regional markets by country and the breakdown of each national market by Application, Technology, and Fixation over the forecast years are also included.
Key Companies
The report also covers the current competitive scenario and profiles key vendors including market leaders and important emerging players. A selection of companies profiled in this report includes:
• Abbott Laboratories
• AbbVie Inc.
• Abiomed
• Asahi Kasei Kuraray Medical Co., Ltd.
• Baxter International Inc.
• BionX Medical Technologies, Inc.
• Boston Scientific Corporation
• Cochlear Ltd.
• Cyberonics Inc.
• Edwards Lifesciences Corporation
• Ekso Bionics Holdings Inc.
• LivaNova PLC
• Lockheed Martin Corporation
• Medtronic plc
• Orthofix Holdings Inc.
• Retina Implant Ag
• ReWalk Robotics Ltd.
• Sarcos Corporation
• Sonova Holding AG
• SynCardia Systems LLC
• William Demant Holding A/S
• Zimmer Biomet Holdings
Reasons to Purchase
• Gain a most comprehensive view on global market with lighting on market outlook, segmentations, dynamics and trends, growth opportunities, risk assessment, critical success factors (CSFs), increasingly attractive segments (IAS), and Porter's Fiver Forces analysis.
• Access identified business opportunities and benchmarked investment strategies.
• Obtain up-to-date data and valuable insights to create regional and national strategies.
• Take wise actions to mitigate potential risk based on the matrix of systematic risk evaluation.
• Outperform competitors using the latest market data and research discoveries.
• Support internal and external presentations with reliable data and profound analysis.
• Backed up by premium primary and secondary information sources with inputs derived from industry professionals across the value chain.
• Supported by free customer services before and after sales.
1 Introduction 10
1.1 Industry Definition and Research Scope 10
1.1.1 Industry Definition 10
1.1.2 Research Scope 11
1.2 Research Methodology 14
1.2.1 Overview of Market Research Methodology 14
1.2.2 Market Assumption 15
1.2.3 Secondary Data 15
1.2.4 Primary Data 15
1.2.5 Data Filtration and Model Design 16
1.2.6 Market Size/Share Estimation 17
1.2.7 Research Limitations 18
1.3 Executive Summary 19
2 Market Overview and Dynamics 21
2.1 Market Size and Forecast 21
2.1.1 Impact of COVID-19 on World Economy 22
2.1.2 Impact of COVID-19 on the Market 26
2.1.3 Impact of Russia-Ukraine Conflict 28
2.1.4 Impact of Israel-Palestine War 30
2.2 Major Growth Drivers 31
2.3 Market Restraints and Challenges 36
2.4 Emerging Opportunities and Market Trends 39
2.5 Porter's Fiver Forces Analysis 42
3 Segmentation of Global Market by Application 46
3.1 Market Overview by Application 46
3.2 Medical Bionics 49
3.2.1 Bionic Orthopaedic 51
3.2.2 Bionic Heart 52
3.2.3 Bionic Brain 53
3.2.4 Bionic Ear 54
3.2.5 Bionic Eye/Vision 55
3.3 Defense Bionics 56
3.3.1 Full Body Military Exoskeletons 58
3.3.2 Lower Body Powered Military Exoskeletons 59
3.3.3 Passive Military Exoskeletons 60
3.3.4 Energy Scavenging Military Exoskeletons 61
3.3.5 Stationary Military Exoskeletons 62
3.4 Industrial Bionics 63
4 Segmentation of Global Market by Technology 64
4.1 Market Overview by Technology 64
4.2 Mechanical Bionics 67
4.3 Electronic Bionics 68
5 Segmentation of Global Market by Fixation 69
5.1 Market Overview by Fixation 69
5.2 Implantable Bionics 72
5.3 Externally Worn Bionics 73
6 Segmentation of Global Market by End User 74
6.1 Market Overview by End User 74
6.2 Hospitals 77
6.3 Military 78
6.4 Clinics & Diagnostic Centers 79
6.5 Industrial Users 80
6.6 Other End Users 81
7 Segmentation of Global Market by Region 82
7.1 Geographic Market Overview 2023-2033 82
7.2 North America Market 2023-2033 by Country 87
7.2.1 Overview of North America Market 87
7.2.2 U.S. 91
7.2.3 Canada 95
7.2.4 Mexico 97
7.3 European Market 2023-2033 by Country 99
7.3.1 Overview of European Market 99
7.3.2 Germany 103
7.3.3 U.K. 105
7.3.4 France 107
7.3.5 Spain 109
7.3.6 Italy 111
7.3.7 Russia 113
7.3.8 Rest of European Market 115
7.4 Asia-Pacific Market 2023-2033 by Country 117
7.4.1 Overview of Asia-Pacific Market 117
7.4.2 Japan 121
7.4.3 China 124
7.4.4 Australia 126
7.4.5 India 128
7.4.6 South Korea 130
7.4.7 Rest of APAC Region 132
7.5 South America Market 2023-2033 by Country 134
7.5.1 Argentina 138
7.5.2 Brazil 140
7.5.3 Chile 142
7.5.4 Rest of South America Market 144
7.6 MEA Market 2023-2033 by Country 145
7.6.1 UAE 149
7.6.2 Saudi Arabia 151
7.6.3 South Africa 153
7.6.4 Other National Markets 155
8 Competitive Landscape 156
8.1 Overview of Key Vendors 156
8.2 New Product Launch, Partnership, Investment, and M&A 159
8.3 Company Profiles 160
Abbott Laboratories 160
AbbVie Inc. 162
Abiomed 163
Asahi Kasei Kuraray Medical Co., Ltd. 164
Baxter International Inc. 165
BionX Medical Technologies, Inc. 166
Boston Scientific Corporation 167
Cochlear Ltd. 168
Cyberonics Inc. 169
Edwards Lifesciences Corporation 170
Ekso Bionics Holdings Inc. 171
LivaNova PLC 172
Lockheed Martin Corporation 173
Medtronic plc 174
Orthofix Holdings Inc. 175
Retina Implant Ag 176
ReWalk Robotics Ltd. 177
Sarcos Corporation 178
Sonova Holding AG 179
SynCardia Systems LLC 180
William Demant Holding A/S 181
Zimmer Biomet Holdings 182
9 Investing in Bionics Industry: Risk Assessment and Management 183
9.1 Risk Evaluation of Global Market 183
9.2 Critical Success Factors (CSFs) 189
RELATED REPORTS 192
Opportunity and Strategy Analysis
This report focuses on identifying opportunities and strategies for investing in the global medical bionics market within the forecast period. It provides a complete analysis of the global market both quantitatively and qualitatively. The quantitative analysis...
Opportunity and Strategy Analysis
This report focuses on identifying opportunities and strategies for investing in the global bionics market within the forecast period. It provides a complete analysis of the global market both quantitatively and qualitatively. The quantitative analysis include...
Overview of the Global Artificial Organs and Bionics Market:
The report discusses everything a marketer requires before investing in the global Artificial Organs and Bionics Market during the forecast period 2023-20...
The global Artificial Organs and Bionics market is expected to reach US$ XX Million by 2028, with a CAGR of XX% from 2023 to 2028, based on HNY Research newly published report.
The prime objective of this report is to provide the insights on the post COVID-19 impact which will help market player...
The global Bionics and Smart Prosthesis market is expected to reach US$ XX Million by 2028, with a CAGR of XX% from 2023 to 2028, based on HNY Research newly published report.
The prime objective of this report is to provide the insights on the post COVID-19 impact which will help market players...
The global Medical Bionics market is expected to reach US$ XX Million by 2028, with a CAGR of XX% from 2023 to 2028, based on HNY Research newly published report.
The prime objective of this report is to provide the insights on the post COVID-19 impact which will help market players in this fiel...
Overview of the Global Artificial Organs and Bionics Market:The report discusses everything a marketer requires before investing in the global Artificial Organs and Bionics Market during the forecast period 2023-2030. It provides detailed insight into current trends, marke...
The global Vital Organs Support Systems and Medical Bionics market is expected to reach US$ XX Million by 2028, with a CAGR of XX% from 2023 to 2028, based on HNY Research newly published report.
The prime objective of this report is to provide the insights on the post COVID-19 impact which will...
The global Brain Bionics market is expected to reach US$ XX Million by 2028, with a CAGR of XX% from 2023 to 2028, based on HNY Research newly published report.
The prime objective of this report is to provide the insights on the post COVID-19 impact which will help market players in this field ...
The global Artificial Organ And Bionics market is expected to reach US$ XX Million by 2028, with a CAGR of XX% from 2023 to 2028, based on HNY Research newly published report.
The prime objective of this report is to provide the insights on the post COVID-19 impact which will help market players...